TNFα antagonists in rheumatoid arthritis patients seen in everyday practice

被引：15
|
作者：
Falgarone, Geraldine [1 ]
Duclos, Muriel [2 ]
Boissier, Marie-Christophe [2 ]
机构：
[1] Hop Avicenne, Serv Rhumatol, CHU Avicenne, F-93009 Bobigny, France
[2] Univ Paris 13, INSERM ER118, Avicenne Teaching Hosp, Rheumatol Dept,AP HP, Bobigny, France
来源：
JOINT BONE SPINE | 2007年 / 74卷 / 06期
关键词：
TNF alpha antagonists; real-world practice; everyday practice; rheumatoid arthritis;
D O I：
10.1016/j.jbspin.2007.10.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：523 / 526
页数：4
相关论文
共 50 条
  • [41] Serious infections under treatment with TNF-α antagonists compared to traditional DMARDs in patients with rheumatoid arthritis
    N. Inanc
    H. Direskeneli
    Rheumatology International, 2006, 27 : 67 - 71
  • [42] Baseline serum RANKL level as a predictor of remission in rheumatoid arthritis patients treated with TNF antagonists.
    Gonzalez-Alvaro, Isidoro
    Ortiz, Ana M.
    Orte, Javier
    Balsa, Alejandro
    Laffon, Armando
    Garcia-Vicuña, Rosario
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S418 - S418
  • [43] Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
    Germano, Valentina
    Cattaruzza, Maria Sofia
    Osborn, John
    Tarantino, Aurora
    Di Rosa, Roberta
    Salemi, Simonetta
    D'Amelio, Raffaele
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [44] Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study
    Johnson, Jennifer
    Yeter, Karen
    Rajbhandary, Rosy
    Neal, Rebekah
    Tian, Qingyun
    Jian, Jinlong
    Fadle, Natalie
    Thurner, Lorenz
    Liu, Chuanju
    Stohl, William
    CLINICAL RHEUMATOLOGY, 2017, 36 (03) : 507 - 516
  • [45] Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study
    Jennifer Johnson
    Karen Yeter
    Rosy Rajbhandary
    Rebekah Neal
    Qingyun Tian
    Jinlong Jian
    Natalie Fadle
    Lorenz Thurner
    Chuanju Liu
    William Stohl
    Clinical Rheumatology, 2017, 36 : 507 - 516
  • [46] Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
    Valentina Germano
    Maria Sofia Cattaruzza
    John Osborn
    Aurora Tarantino
    Roberta Di Rosa
    Simonetta Salemi
    Raffaele D’Amelio
    Journal of Translational Medicine, 12
  • [47] Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritis
    Wu, Eric
    Chen, Lei
    Birnbaum, Howard
    Yang, Elaine
    Cifaldi, Mary
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (08) : 2229 - 2240
  • [48] Serious infections under treatment with TNF-α antagonists compared to traditional DMARDs in patients with rheumatoid arthritis
    Inanc, N.
    Direskeneli, H.
    RHEUMATOLOGY INTERNATIONAL, 2006, 27 (01) : 67 - 71
  • [49] Health-related quality of life and satisfaction in patients with rheumatoid arthritis treated with TNF-antagonists
    Del Pozo Ruiz, J. J.
    Ortega Valin, L.
    Perez Sandoval, T.
    Martin Sanchez, V.
    Gutierrez, E.
    Jimenez Morales, Alberto
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 296 - 297
  • [50] Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: Three centers experience
    Salgado, Eva
    Campos, Jose
    Moreira-Navarrete, Virginia
    Mulero, Juan
    Navarro, Federico
    Perez-Pampin, Eva
    Carmoa, Loreto
    Gomez-Reino, Juan
    JOINT BONE SPINE, 2013, 80 (04) : 438 - 440
12345